Hepatocellular carcinoma in patients without cirrhosis

doi:10.3748/wjg.v31.i23.107100

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-5)

Sum=0

Jun 21, 2025 (publication date) through Jun 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 21, 2025; 31(23): 107100
Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.107100

Full Size Figure Download Figure

Figure 4 Hypothesis of the development of hepatocellular carcinoma in individuals with metabolic dysfunction-associated steatotic liver disease. Akt: Protein kinase B; IGF-1: Insulin-like growth factor-1; MAPK: Mitogen-activated protein kinase; mTOR: Mammalian target of rapamycin; PI3K: Phosphoinositide 3-kinase. Created in BioRender (Supplementary material).

Citation: Sato-Espinoza K, Valdivia-Herrera M, Chotiprasidhi P, Diaz-Ferrer J. Hepatocellular carcinoma in patients without cirrhosis. World J Gastroenterol 2025; 31(23): 107100
URL: https://www.wjgnet.com/1007-9327/full/v31/i23/107100.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i23.107100